• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    1.79 Up 0.05(2.87%) Dec 19, 4:10PM EST
    |After Hours : 1.79 0.00 (0.00%) Dec 19, 4:48PM EST
    Add to Portfolio
    Prev Close:1.74
    Open:1.73
    Bid:1.80 x 20000
    Ask:1.90 x 7100
    1y Target Est:4.31
    Beta:1.51
    Earnings Date:Mar 4 - Mar 9 (Est.)
    Day's Range:1.72 - 1.88
    52wk Range:0.97 - 2.12
    Volume:2,449,006
    Avg Vol (3m):1,137,470
    Market Cap:268.81M
    P/E (ttm):N/A
    EPS (ttm):-0.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBUp 2.87%268.81M
    LLYDown 0.07%77.44B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):56.66
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.24
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback